Physician profile
John David Marett
NPI 1821559519
$397.38
in general payments reported to CMS, 2019-2025
12 companies · $70.82 in 2025
The $70.82 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.32 · 2023: $164 · 2024: $127 · 2025: $70.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.28 | 2023-2025 | |
| Lilly USA, LLC | $45.27 | 2023 | Mounjaro, Emgality, Jardiance |
| Dexcom, INC. | $37.40 | 2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $25.67 | 2024 | Minimed 780g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.97 | 2024 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.33 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.87 | 2022 | |
| Pfizer INC. | $17.98 | 2024 | |
| Harmony Biosciences LLC | $16.45 | 2022 | |
| Agios Pharmaceuticals, INC. | $16.05 | 2023 | Pyrukynd |
| Philips North America LLC | $15.68 | 2025 | Vest Therapy Und |
| Axsome Therapeutics, INC. | $13.43 | 2023 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Marett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.